Harford Simon N.R.
Chief Financial Officer
Officer
Latest Insider Transactions
5 transactions (past 365 days)
| 2026-04-27 | 2026-04-27 | FOLD Amicus Therapeutics, Inc. | CFO | Disposition | 150,517 | $9.41 | $1,416,365 |
| 2026-04-27 | 2026-04-27 | FOLD Amicus Therapeutics, Inc. | CFO | Disposition | 189,043 | $12.62 | $2,385,723 |
| 2026-04-27 | 2026-04-27 | FOLD Amicus Therapeutics, Inc. | CFO | Disposition | 99,073 | $14.24 | $1,410,800 |
| 2026-04-27 | 2026-04-27 | FOLD Amicus Therapeutics, Inc. | CFO | Disposition | 143,595 | $14.50 | $2,082,128 |
| 2025-12-30 | 2025-12-26 | FOLD Amicus Therapeutics, Inc. | CFO | Tax Payment | 71,303 | $14.25 | -$1,016,068 |
FOLD
CFO
Disposition
$1.4M
150,517 shares @ $9.41
Filed 2026-04-27Trade 2026-04-27
Amicus Therapeutics, Inc.FOLD
CFO
Disposition
$2.4M
189,043 shares @ $12.62
Filed 2026-04-27Trade 2026-04-27
Amicus Therapeutics, Inc.FOLD
CFO
Disposition
$1.4M
99,073 shares @ $14.24
Filed 2026-04-27Trade 2026-04-27
Amicus Therapeutics, Inc.FOLD
CFO
Disposition
$2.1M
143,595 shares @ $14.50
Filed 2026-04-27Trade 2026-04-27
Amicus Therapeutics, Inc.FOLD
CFO
Tax Payment
-$1M
71,303 shares @ $14.25
Filed 2025-12-30Trade 2025-12-26
Amicus Therapeutics, Inc.